FDA Approved: ACULAR LS — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ACULAR LS (ketorolac tromethamine) by Allergan, Inc. This action updates the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• ACULAR LS (Ketorolac tromethamine)

Snippet

SUPPL AP for ACULAR LS (KETOROLAC TROMETHAMINE)